BRAF and cancer: CRC with the BRAF and KRAS mutations, derived from the serrated or conventional adenoma-to-carcinoma pathways (discussed further in detail later), are also represented by distinct epigenetic subtypes that may represent basic differences in transcriptional programs involved in these cancers.